Sleeve gastrectomy.
Conditions
Interventions
Intervention 1: Intervention group: ropivacaine 0.5% 20ml + normal saline up to the final volume of 40ml, intraperitoneally. Intervention 2: Intervention group: ropivacaine 0.5% 20 ml + dexmedetomidin
Sponsors
Tehran University of Medical Sciences
Anesthesiology, critical care and pain management research center
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The patient is a candidate for bariatric laparoscopic surgery; The patient's age is over 18 years; The patient is classified as ASA class 1 to 3 according to the American Society of Anesthesiologists;
Exclusion criteria
Exclusion criteria: The patient has an opioid addiction; The patient has a previous history of abdominal surgery; The patient has a history of allergy to any of the drugs under study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: On 0,2,4,8,12,24 hours. Method of measurement: VAS scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Opioid dosage requirement. Timepoint: On 0,2,4,8,12,24 hours. Method of measurement: Medical record.;Post anesthetic nausea and vomiting. Timepoint: On 0,2,4,8,12,24 hours. Method of measurement: Patient examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSamira Shokri
Tehran University of Medical Sciences
Outcome results
None listed